GMCA 1635 Research into Emerging Drug Trends across Greater Manchester
Overview
Summary, notice description and lot information
The Greater Manchester Combined Authority (GMCA) is actively seeking bids for the project titled "GMCA 1635 Research into Emerging Drug Trends across Greater Manchester," focusing on analytical testing and investigation of emerging drug trends in the region. This service is part of their commitment to maintaining a comprehensive Drugs Intelligence System. The procurement process is at the tender stage, with submissions required via The Chest by 12 January 2026.
The initiative is valued at approximately £393,726, potentially extending to £472,471, and falls under the industry category of research and development services, health and social work services, and community services. Located in the UKD3 region, GMCA represents a sub-central public authority engaged in the open procedure procurement method, compliant with the UK's broader procurement framework. This tender offers significant opportunities for growth to businesses capable of providing comprehensive research and analytical services related to drug trends and public health.
Companies specializing in research and development, particularly those with expertise in social work or community services, are ideally suited to this opportunity. Small and medium-sized enterprises and VCSEs are encouraged to apply, leveraging their potential to contribute to public health innovations. Success in this tender could enhance the business profile and expand capabilities in public service research within Greater Manchester and beyond.
The Greater Manchester Combined Authority (GMCA) is seeking to commission a service to provide analytical testing of substances of concern, and research into emerging drug trends across the city region. The Greater Manchester Combined Authority (GMCA) co-ordinates a Drugs Intelligence System to provide up to date information on drug use across Greater Manchester including emerging risks, drug alerts, and information on drug related deaths. The contract will be for an initial period of 3 years, with the option to renew for two further 12-month periods.
A GMCA Proposed Budget for the Research into Emerging Drug Trends tender, has been supplied in the Pricing document in detail for the initial contracting period. All tender response documents can only be accessed via The Chest (the North West Procurement Portal) - https://www.the-chest.org.uk/.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
The contract period is three years.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in Manchester
- P-0376 New Refugee Housing Integration Hub in Manchester
- Provision of Restricted Eligibility Support in Manchester
- GMCA 1508 - Race Equality Panel Facilitation in Manchester
- Greater Manchester, East Cheshire and Glossop Abdominal Aortic Aneurysm (AAA) Service in Manchester
- Pathology Service Joint Venture in Manchester
- TC1193 Framework for Supported Living and Day Opportunities in Manchester